
Neeha Zaidi, MD
Medical Oncology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Neeha Zaidi
Primary Academic Title
Associate Professor of Oncology
Background
Dr. Neeha Zaidi is a physician scientist and a medical oncologist, caring for patients with pancreatic and colorectal cancers.
Dr. Zaidi received her undergraduate degree (Magna Cum Laude) in Biology from Cornell University and earned her M.D. from the Mount Sinai School of Medicine where she graduated with Distinction in Research. During medical school, she spent a year as a Howard Hughes Medical Institute (HHMI) Research Fellow at The Rockefeller University studying dendritic cell vaccines. She completed her residency in internal medicine at Weill Cornell and subsequently received an Intramural Research Training Award to perform a year-long post-doctoral fellowship at the Vaccine Research Center (NIAID) at the NIH. She then completed a fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Zaidi joined the Johns Hopkins faculty in 2019.
Dr. Zaidi’s laboratory focuses on developing novel personalized immunotherapy approaches for the treatment and prevention of pancreatic cancer.
Dr. Zaidi has most recently been recognized with an ASCO Career Development Award and a NCI K08 Award.
Centers and Institutes
Selected Publications
Zaidi N, Quezada S, Kuroiwa JM, Zhang L, Jaffee EM, Steinman RM, Wang B (2019) Anti-CTLA-4 therapy synergizes with dendritic cell targeting vaccines to promote effector T cell infiltration in an IL-3–dependent manner. Annals of the New York Academy of Sciences 1445: 62-73. PMID: 30954313
Zaidi N, Soban M, Chen F, Mathew J, Kinkead, HL, Armstrong TA, Haider S, Jaffee EM (2020) Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development. (2020) JCI Insight 5(17): 136911. PMID: 32879142
Kinkead HL, Hopkins A, Lutz E, Wu AA, Yarchoan M, Cruz K, Woolman S, Vithayathil T, Glickman LH, Ndubaku CO, McWhirter SM, Dubensky TW Jr, Armstrong TD, Jaffee EM*, Zaidi N*. (2018) Combining STING–based neoantigen–targeted vaccine with checkpoint modulators enhances anti–tumor immunity in murine pancreatic cancer. JCI Insight 3 (20): pii: 122857. PMID: 30333318. [*EMJ and NZ Corresponding Authors].
Lynn GM, Sedlik C, Baharom F, Zhu Y, Ramirez-Valdez RA, Coble VL, Tobin K, Nichols SR, Itzkowitz Y, Zaidi N, Gammon JM, Blobel NJ, Denizeau J, de la Rochere P, Francica BJ, Decker B, Maciejewski M, Cheung J, Yamane H, Smelkinson MG, Francica JR, Laga R, Bernstock JD, Seymour LW, Drake CG, Jewell CM, Lantz O, Piaggio E, Ishizuka AS, Seder RA. (2020) Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens. Nature Biotechnology 38: 320-332. PMID: 31932728
Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, Garrido-Laguna I, Lau MW, Johnson T, Krishnamurthi S, Moravek C, O’Reilly EM, Philip PA, Pant S, Shah MA, Sahai V, Uronis HE, Zaidi N, Laheru D. Metastatic Pancreatic Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 2020. PMID: 32755482
Honors
- Career Development Award, ASCO
- NCI K08 Career Development Award
- Career Enhancement Award, GI SPORE, 11/1/19
- Young Investigator Award, American Society of Clinical Oncology, 7/1/18
- The Linda Rubin Fellowship in Pancreatic Cancer Research and Patient Care (2nd recipient), Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 7/1/18
- Member of ASCO Expert Panel for Metastatic Pancreatic Cancer Guidelines, American Society of Clinical Oncology, 7/1/18
- Young Investigator, Stand Up 2 Cancer, 9/1/17
- Inaugural PSTP Scholar, Physician-Scientist Training Program, Johns Hopkins University School of Medicine, 7/1/17
- Intramural Research Training Award, National Institute of Health, 7/1/15
- Distinction in Research, Mount Sinai School of Medicine, 5/1/15
- Jeffrey Modell Clinical Immunology Prize, Mount Sinai School of Medicine, 5/1/12
- American Physician-Scientist Association (APSA) Annual Meeting Travel Award, Joint ASCI-AAP-APSA Meeting, 4/1/12
- Howard Hughes Medical Research Fellow, HHMI, 7/1/11
- Magna Cum Laude, Cornell University, 5/1/07
- Dean's List, Cornell University, 7/1/05
Memberships
- American Society of Cancer Oncology,
Member
- American Association of Cancer Research,
Member
- American Physician–Scientist Association,
Member
Locations
- Skip Viragh Outpatient Cancer Center
- 201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287
- phone: 410-955-8964
- fax: 410-367-2194
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Oncology, 2019New York-Presbyterian Weill Cornell
Residency, Internal Medicine, 2015Mount Sinai School of Medicine
Medical Education, MD, 2012Board Certifications
Internal Medicine
American Board of Internal Medicine, 2015Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)